86 related articles for article (PubMed ID: 21307089)
1. Signalling during an ischaemic preconditioning protocol: new role players?
Lochner A
Cardiovasc Res; 2011 Apr; 90(1):5-6. PubMed ID: 21307089
[No Abstract] [Full Text] [Related]
2. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
[TBL] [Abstract][Full Text] [Related]
3. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
[TBL] [Abstract][Full Text] [Related]
4. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism.
Ha T; Hua F; Liu X; Ma J; McMullen JR; Shioi T; Izumo S; Kelley J; Gao X; Browder W; Williams DL; Kao RL; Li C
Cardiovasc Res; 2008 Jun; 78(3):546-53. PubMed ID: 18267957
[TBL] [Abstract][Full Text] [Related]
6. No risk, no ... cardioprotection? A critical perspective.
Heusch G
Cardiovasc Res; 2009 Nov; 84(2):173-5. PubMed ID: 19713282
[No Abstract] [Full Text] [Related]
7. Remote preconditioning provides potent cardioprotection via PI3K/Akt activation and is associated with nuclear accumulation of β-catenin.
Li J; Xuan W; Yan R; Tropak MB; Jean-St-Michel E; Liang W; Gladstone R; Backx PH; Kharbanda RK; Redington AN
Clin Sci (Lond); 2011 May; 120(10):451-62. PubMed ID: 21143191
[TBL] [Abstract][Full Text] [Related]
8. Regular treadmill exercise restores cardioprotective signaling pathways in obese mice independently from improvement in associated co-morbidities.
Pons S; Martin V; Portal L; Zini R; Morin D; Berdeaux A; Ghaleh B
J Mol Cell Cardiol; 2013 Jan; 54():82-9. PubMed ID: 23201226
[TBL] [Abstract][Full Text] [Related]
9. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways.
Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715
[TBL] [Abstract][Full Text] [Related]
10. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Human Brain Natriuretic Peptide Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting CD4
Li KP; Zhang HY; Xu XD; Ming-Yang ; Li TJ; Song ST
Cardiovasc Ther; 2020; 2020():1389312. PubMed ID: 32788926
[TBL] [Abstract][Full Text] [Related]
12. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
14. Ischemic postconditioning in pigs: no causal role for RISK activation.
Skyschally A; van Caster P; Boengler K; Gres P; Musiolik J; Schilawa D; Schulz R; Heusch G
Circ Res; 2009 Jan; 104(1):15-8. PubMed ID: 19038864
[TBL] [Abstract][Full Text] [Related]
15. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
Fan WJ; van Vuuren D; Genade S; Lochner A
Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
[TBL] [Abstract][Full Text] [Related]
16. Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: Characterisation in the bi-phasic profile of early and late protection.
Bell RM; Clark JE; Hearse DJ; Shattock MJ
Cardiovasc Res; 2007 Jan; 73(1):153-63. PubMed ID: 17126307
[TBL] [Abstract][Full Text] [Related]
17. Delayed remote ischemic preconditioning produces an additive cardioprotection to sevoflurane postconditioning through an enhanced heme oxygenase 1 level partly via nuclear factor erythroid 2-related factor 2 nuclear translocation.
Zhou C; Li H; Yao Y; Li L
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):558-66. PubMed ID: 24651515
[TBL] [Abstract][Full Text] [Related]
18. How does Viagra protect the ischemic heart?
Xia Y
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1209-10. PubMed ID: 19346460
[No Abstract] [Full Text] [Related]
19. Glucocorticoids differentially modulate insulin-mediated protein and glycogen synthetic signaling downstream of protein kinase B in rat myocardium.
Wu Y; Barrett EJ; Long W; Liu Z
Endocrinology; 2004 Mar; 145(3):1161-6. PubMed ID: 14630710
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen plays a permissive role in cardioprotection.
Cohen MV; Downey JM
Cardiovasc Res; 2008 Aug; 79(3):353-4. PubMed ID: 18539628
[No Abstract] [Full Text] [Related]
[Next] [New Search]
